Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 CAD | 0.00% | -16.67% | +56.25% |
Sales 2022 | 2.67M 1.95M | Sales 2023 | 149K 109K | Capitalization | 10.55M 7.72M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.2M | Net income 2023 | -5M -3.66M | EV / Sales 2022 | 6.37 x |
Net Debt 2022 | 5.76M 4.22M | Net Debt 2023 | 8.51M 6.23M | EV / Sales 2023 | 128 x |
P/E ratio 2022 |
-2.79
x | P/E ratio 2023 |
-2.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.07% |
Latest transcript on Kane Biotech Inc.
1 week | -16.67% | ||
Current month | +4.17% | ||
3 months | +19.05% | ||
6 months | +66.67% | ||
Current year | +56.25% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 17-09-04 |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 22-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 10-09-14 |
Chairman | 59 | Feb. 19 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.125 | 0.00% | 8,000 |
24-05-27 | 0.125 | -3.85% | 126,000 |
24-05-24 | 0.13 | -13.33% | 294,000 |
24-05-23 | 0.15 | +3.45% | 3,013 |
24-05-22 | 0.145 | -3.33% | 374,056 |
Delayed Quote Toronto S.E., May 28, 2024 at 02:06 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+56.25% | 12.08M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.66% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- KNE Stock